What was recalled
This page synthesizes the chickpea protein framework around commercial pet food, with particular focus on the grain-free DCM investigation connection. Chickpea (Cicer arietinum) is one of the oldest cultivated legumes, with archaeological evidence of cultivation dating to approximately 7000 BCE in the Fertile Crescent. Global chickpea production is dominated by India (approximately 70% of total production), reflecting central role in Indian cuisine through hummus, chana masala, falafel, and many other preparations. Other major production regions include Australia, Turkey, Pakistan, Iran, Ethiopia, Mexico, and the United States. The two major commercial chickpea types are desi (smaller, darker seeds with thicker seed coat, dominant in South Asia) and kabuli (larger, lighter seeds with thinner seed coat, dominant in Mediterranean and Western markets including most pet food formulation).
The nutritional and protein-functional framework of chickpea is broadly similar to other pulse legumes. Whole chickpea has approximately 20% protein, 60% carbohydrate (mostly starch, with some dietary fiber), 6% fat, and substantial mineral content including iron, manganese, magnesium, and phosphorus. Commercial chickpea protein concentrate and isolate products achieve 70-90% protein on dry-matter basis through controlled extraction (typically alkaline extraction followed by isoelectric precipitation, similar to pea and lentil protein extraction). The amino acid profile is relatively rich in lysine but limiting in methionine and tryptophan, like other pulse legumes. The profile makes chickpea functionally interchangeable with pea and lentil in many pet food formulation contexts; brands selecting chickpea over pea typically do so for ingredient diversification, sourcing flexibility, or marketing differentiation rather than fundamentally different nutritional framework.
The grain-free DCM cluster connection is the consequential safety framework. The 2018-2023 FDA investigation of dilated cardiomyopathy (DCM) in dogs consuming grain-free pulse-legume-heavy diets identified chickpea, pea, and lentil as the three primary pulse legumes in the case cluster. The mechanistic basis remains incompletely resolved (see our grain-free DCM controversy and taurine biosynthesis precursors controversy pages for the mechanistic hypothesis frameworks). The investigation has not closed; pet food brands using chickpea in grain-free formulations have generally adopted synthetic taurine supplementation as defensive measure pending mechanistic resolution. The case cluster has disproportionately featured Golden Retriever and certain other susceptible breeds; risk magnitude for typical breeds on chickpea-containing grain-free formulations appears low but the elevated risk for susceptible breeds is meaningful.
Why it was recalled
The structural concerns have three layers. Layer one — the grain-free DCM cluster includes chickpea-containing formulations: the 2018-2023 FDA investigation identified chickpea as one of the three primary pulse legumes (alongside pea and lentil) in the grain-free DCM case cluster. The mechanistic basis has not been definitively established, but the statistical association between grain-free pulse-legume-heavy diets and DCM cases is well-documented. Chickpea-anchored or chickpea-supplemented grain-free formulations should be evaluated within the broader grain-free DCM framework, particularly for susceptible breeds (Golden Retriever, American Cocker Spaniel, Doberman Pinscher, Boxer).
Layer two — amino acid profile differences from pea and lentil are modest but consequential: chickpea, pea, and lentil are functionally interchangeable in many formulation contexts, but each has slightly different amino acid profile, anti-nutrient content (phytate, lectin, trypsin inhibitor), and processing-stability characteristics. Chickpea has slightly lower lysine than pea per gram of protein but similar methionine and tryptophan limitation. Brand-level disclosure of which specific pulse legumes are used in a formulation, and at what relative percentages, is uneven across the category. Pet owners with concerns about a specific pulse legume (chickpea, pea, or lentil) cannot easily verify exclusion through ingredient labeling alone.
Layer three — chickpea ingredient processing varies substantially: commercial pet food chickpea inclusion appears in multiple forms with different processing footprint and nutritional profile: whole chickpea flour (minimally processed, retains anti-nutrient content unless processed downstream); dehulled chickpea (reduced fiber content); chickpea protein concentrate (60-70% protein through controlled extraction); chickpea protein isolate (85-90% protein through more rigorous extraction); and fermented chickpea (reduced anti-nutrient content through bacterial fermentation). Anti-nutrient content (phytate binding minerals, lectins potentially affecting gut function, trypsin inhibitor affecting protein digestibility) varies substantially across these processing forms. Brand-level disclosure of chickpea processing form is uncommon.
Health risks for your pet
Chickpea protein at typical pet food inclusion rates from established manufacturers is well-tolerated in most dogs and cats. Documented concerns include grain-free DCM cluster framework (covered above and on our grain-free DCM controversy page), particularly for Golden Retriever and certain other susceptible breeds; anti-nutrient content in minimally processed chickpea inclusions (phytate, lectins, trypsin inhibitor) that may affect mineral absorption and protein digestibility in some formulations; methionine limitation that requires complementary methionine supplementation or animal protein co-formulation to meet feline and some canine requirements; and allergic reaction in pets with confirmed chickpea or legume sensitivity, though chickpea allergy is less common than pea or soy allergy in companion animals.
The pet-food-specific concern is recognizing the grain-free DCM exposure framework for susceptible breeds. Commercial maintenance pet food from established manufacturers using chickpea in grain-free formulations generally adopts synthetic taurine supplementation as defensive measure pending mechanistic resolution of the DCM investigation. Pet owners with susceptible-breed dogs (Golden Retriever, American Cocker Spaniel, Doberman Pinscher, Boxer) on chickpea-containing grain-free formulations warrant veterinary cardiology evaluation including echocardiography and serum taurine assessment. For typical breeds without elevated DCM susceptibility, the precautionary value of chickpea-anchored grain-free vs grain-inclusive choice is lower.
What to do if you bought affected product
Pet owners can interpret chickpea pet food inclusion appropriately through several practical approaches: (1) recognize the grain-free DCM cluster framework — the 2018-2023 FDA investigation identified chickpea, pea, and lentil as the three primary pulse legumes in the case cluster; chickpea-anchored or chickpea-supplemented grain-free formulations should be evaluated within this broader framework; (2) seek veterinary cardiology evaluation for susceptible-breed dogs on chickpea-containing grain-free formulations — Golden Retriever, American Cocker Spaniel, Doberman Pinscher, Boxer warrant echocardiography and serum taurine assessment; (3) consider grain-inclusive alternatives for susceptible breeds — the precautionary approach for Golden Retrievers and similarly susceptible breeds is to feed grain-inclusive formulations with adequate animal-protein content; (4) distinguish chickpea processing forms — whole chickpea flour, dehulled chickpea, chickpea protein concentrate, chickpea protein isolate, and fermented chickpea have different anti-nutrient content and nutritional profile; brand-level disclosure of processing form is uncommon but worth requesting from customer service; (5) understand the methionine limitation framework — chickpea protein requires complementary methionine supplementation or animal protein co-formulation to meet feline and some canine requirements; commercial pet food formulations using chickpea as primary protein source typically include synthetic methionine; (6) watch for allergic reaction in pets with confirmed legume sensitivity — chickpea allergy is less common than pea or soy allergy in companion animals but should be considered in pets with documented legume cross-reactivity.
How this affects KibbleIQ’s grade
The KibbleIQ rubric v15 evaluates grain-free pulse-legume-heavy formulations through the broader grain-free DCM framework per our published methodology, with chickpea joining pea and lentil as the three primary pulse legumes in the case cluster. Future rubric extension under consideration: chickpea-anchored or chickpea-supplemented grain-free formulations without synthetic taurine supplementation or without sulfur amino acid analysis transparency would warrant scoring caution; formulations with explicit synthetic taurine supplementation and processing transparency would warrant favorable scoring weight. The grain-free DCM framework is covered in detail on our grain-free DCM controversy page, the taurine biosynthesis precursor framework on our taurine biosynthesis precursors page, and the related plant protein frameworks on our pea protein controversy and plant protein sustainability LCA controversy pages. For now, our recommendation: recognize chickpea-containing grain-free formulations within the grain-free DCM framework, seek veterinary cardiology evaluation for susceptible breeds, and consider grain-inclusive alternatives for breeds with elevated DCM susceptibility.